GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 296 filers reported holding GUARDANT HEALTH INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255 | -13.9% | 8,616 | +4.2% | 0.00% | 0.0% |
| Q2 2023 | $296 | +16.5% | 8,272 | -23.6% | 0.00% | 0.0% |
| Q1 2023 | $254 | -9.3% | 10,823 | +5.3% | 0.00% | 0.0% |
| Q4 2022 | $280 | -100.0% | 10,278 | -20.9% | 0.00% | -60.0% |
| Q3 2022 | $699,000 | +20.7% | 12,986 | -9.5% | 0.01% | +25.0% |
| Q2 2022 | $579,000 | -50.9% | 14,354 | -19.4% | 0.00% | -33.3% |
| Q1 2022 | $1,179,000 | -29.1% | 17,806 | +7.1% | 0.01% | -14.3% |
| Q4 2021 | $1,663,000 | -3.3% | 16,629 | +20.9% | 0.01% | -22.2% |
| Q3 2021 | $1,720,000 | +25.6% | 13,756 | +24.8% | 0.01% | +12.5% |
| Q2 2021 | $1,369,000 | +8.9% | 11,020 | +33.8% | 0.01% | +14.3% |
| Q1 2021 | $1,257,000 | +45.3% | 8,236 | +22.8% | 0.01% | +40.0% |
| Q4 2020 | $865,000 | +137.6% | 6,708 | +106.2% | 0.01% | +150.0% |
| Q3 2020 | $364,000 | -97.5% | 3,253 | -98.1% | 0.00% | -98.3% |
| Q2 2019 | $14,451,000 | – | 167,388 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |